NewGenIvf Group Ltd

NAS:NIVFHealthcarenasdaq_composite

$0.2499−11.73%At closeAt close · Wed 21 Oct · ≈ AED 0.9178 · Market cap $2.3M · Next earnings Wed 3 Mar

USD millions	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Net income	(0.1)	0.5	0.1	(0.5)	9.7	+2152.0%
Depreciation & amortization	0.3	0.3	0.2	0.2	0.5	+142.2%
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	—
Change in working capital	0.7	0.7	(2.1)	(7.8)	(1.6)	+79.4%
Operating cash flow	1.4	(0.5)	(1.8)	(8.3)	(10.9)	−32.2%
Capital expenditure	(0.0)	(0.1)	(0.1)	(0.1)	(5.7)	−10740.0%
Acquisitions	0.0	0.0	0.0	0.0	(1.1)	—
Investing cash flow	(0.0)	(69.7)	(0.1)	(0.1)	(7.6)	−14151.6%
Dividends paid	0.0	0.0	0.0	0.0	0.0	—
Share buybacks	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	0.5	0.1	1.7	8.6	6.3	−26.1%
Financing cash flow	(1.5)	70.3	1.9	8.7	19.0	+118.9%
Free cash flow	1.4	(0.6)	(1.9)	(8.3)	(16.7)	−100.5%
Net change in cash	(0.1)	0.1	(0.0)	0.4	0.3	−25.5%

USD millionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.